top of page



The era of cancer immunotherapy has led to paradigm shifts in the outcomes of various cancers.  SSO-CIC aims to help improve the understanding of cancer immunotherapy and the appropriate use of immunotherapy through educational activities and to work towards collaborative efforts in research where possible. The objectives of the SSO-CIC group are to :


  • To promote the adoption of evidence-based immunotherapy treatments

  • To promote the recruitment of suitable patients onto immunotherapy trials

  • To promote training and awareness on the management of immunotherapy toxicities, biomarkers and response assessment

  • To establish database on immunotherapy including exceptional responses and outcomes in rare tumours

  • To promote awareness amongst non-oncology specialists and the general public, on immunotherapy in cancer

  • To promote collaborations and partnerships in immunotherapy across disciplines both in Singapore and internationally

LCCS logo copy.png

The Lung Cancer Consortium Singapore (LCCS) was first established to bring together the clinical and research community in advancing the diagnosis and management of thoracic cancers. The need to set up the Consortium was driven by differences in lung cancer profiles and survival outcomes observed between the East and West. LCCS was formally set up in 2007 across public hospitals, with the aim of building infrastructure to promote and support nationwide collaboration for lung cancer research. This collaboration was further extended to researchers in the Agency for Science, Technology and Research (A*STAR) in 2013, with the funding support from MOH National Medical Research Council (NMRC). Today, LCCS is broadly divided into two arms, research and education. It continues to provide an important framework for thoracic oncology research in Singapore, and also has a growing emphasis on promoting education to both physicians and the public via events and forums.

Breast Cancer Research Singapore.png


Breast Cancer Research Singapore (BCRS) is a consortium of clinicians and scientists dedicated to breast cancer research in Singapore. It focuses on basic research with a translational endpoint. 

The clinical disciplines of Medical Oncology, Radiation Oncology, Surgical Oncology, Pathology and Radiology of all public hospitals, as well as the major research institutions and academic research centres are represented. Through research, the BCRS aims to innovate and improve breast cancer diagnosis, treatment, detection and prevention in Singapore.

bottom of page